Showing results (1141-1150 of 11,917) with videos related to
Sort By:
Pageof 1,192
The New England Journal of Medicine|October 15, 2010
Antiretroviral treatment for children with peripartum nevirapine exposurePaul Palumbo, Jane C Lindsey, Michael D Hughes, et al.The New England Journal of Medicine|October 15, 2010
ARID1A mutations in endometriosis-associated ovarian carcinomasKimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, et al.The New England Journal of Medicine|October 8, 2010
Clopidogrel with or without omeprazole in coronary artery diseaseDeepak L Bhatt, Byron L Cryer, Charles F Contant, et al.The New England Journal of Medicine|October 8, 2010
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failureBarry M Massie, Christopher M O'Connor, Marco Metra, et al.The New England Journal of Medicine|November 12, 2010
Romiplostim or standard of care in patients with immune thrombocytopeniaDavid J Kuter, Mathias Rummel, Ralph Boccia, et al.The New England Journal of Medicine|February 4, 2011
Fidaxomicin versus vancomycin for Clostridium difficile infectionThomas J Louie, Mark A Miller, Kathleen M Mullane, et al.The New England Journal of Medicine|September 24, 2010
Effect of screening mammography on breast-cancer mortality in NorwayMette Kalager, Marvin Zelen, Frøydis Langmark, et al.The New England Journal of Medicine|April 26, 1990
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allograftsJ P Soulillou, D Cantarovich, B Le Mauff, et al.The New England Journal of Medicine|June 3, 2011
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newbornsSuresh B Boppana, Shannon A Ross, Masako Shimamura, et al.The New England Journal of Medicine|June 7, 2011
Improved survival with vemurafenib in melanoma with BRAF V600E mutationPaul B Chapman, Axel Hauschild, Caroline Robert, et al.Pageof 1,192